UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Seeyond

Seeyond reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 16.7% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 6,369 shares of the healthcare conglomerate’s stock after selling 1,276 shares during the quarter. Seeyond’s holdings in UnitedHealth Group were worth $2,550,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in UNH. Jennison Associates LLC increased its position in UnitedHealth Group by 205.8% during the 2nd quarter. Jennison Associates LLC now owns 1,947,717 shares of the healthcare conglomerate’s stock valued at $779,944,000 after buying an additional 1,310,783 shares in the last quarter. Capital International Investors increased its holdings in shares of UnitedHealth Group by 5.8% in the first quarter. Capital International Investors now owns 18,899,258 shares of the healthcare conglomerate’s stock valued at $7,032,097,000 after purchasing an additional 1,040,094 shares during the period. Lazard Asset Management LLC increased its holdings in shares of UnitedHealth Group by 185.4% in the first quarter. Lazard Asset Management LLC now owns 1,178,666 shares of the healthcare conglomerate’s stock valued at $438,545,000 after purchasing an additional 765,729 shares during the period. Ontario Teachers Pension Plan Board acquired a new position in shares of UnitedHealth Group in the first quarter valued at about $266,424,000. Finally, Geode Capital Management LLC increased its holdings in shares of UnitedHealth Group by 4.7% in the second quarter. Geode Capital Management LLC now owns 15,110,522 shares of the healthcare conglomerate’s stock valued at $6,033,290,000 after purchasing an additional 679,484 shares during the period. 86.21% of the stock is currently owned by institutional investors.

UNH stock traded up $21.93 during midday trading on Thursday, hitting $425.48. 86,825 shares of the company’s stock were exchanged, compared to its average volume of 2,968,564. The business has a 50-day simple moving average of $411.69 and a two-hundred day simple moving average of $405.33. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $401.19 billion, a PE ratio of 26.65, a P/E/G ratio of 1.62 and a beta of 0.77. UnitedHealth Group Incorporated has a 1-year low of $299.60 and a 1-year high of $431.36.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share for the quarter, beating the Zacks’ consensus estimate of $4.41 by $0.11. UnitedHealth Group had a return on equity of 22.15% and a net margin of 5.33%. The business had revenue of $72.34 billion during the quarter, compared to analysts’ expectations of $71.24 billion. During the same period in the previous year, the firm posted $3.51 earnings per share. The company’s revenue was up 11.1% on a year-over-year basis. As a group, research analysts expect that UnitedHealth Group Incorporated will post 18.74 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 21st. Stockholders of record on Monday, September 13th were paid a $1.45 dividend. The ex-dividend date was Friday, September 10th. This represents a $5.80 dividend on an annualized basis and a dividend yield of 1.36%. UnitedHealth Group’s payout ratio is presently 34.36%.

In related news, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction on Tuesday, September 14th. The stock was sold at an average price of $416.75, for a total value of $1,041,875.00. Following the completion of the transaction, the director now directly owns 154,403 shares in the company, valued at $64,347,450.25. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Stephen J. Hemsley sold 60,000 shares of UnitedHealth Group stock in a transaction on Friday, July 16th. The shares were sold at an average price of $420.62, for a total value of $25,237,200.00. Following the completion of the transaction, the director now owns 941,560 shares of the company’s stock, valued at $396,038,967.20. The disclosure for this sale can be found here. Insiders sold 101,438 shares of company stock valued at $42,396,929 over the last ninety days. Insiders own 0.55% of the company’s stock.

UNH has been the topic of several analyst reports. SVB Leerink initiated coverage on UnitedHealth Group in a report on Monday, September 27th. They set an “outperform” rating and a $480.00 target price on the stock. Truist raised their target price on UnitedHealth Group from $480.00 to $500.00 and gave the stock a “buy” rating in a report on Friday, July 16th. Deutsche Bank Aktiengesellschaft raised their target price on UnitedHealth Group from $418.00 to $421.00 and gave the stock a “buy” rating in a report on Tuesday, July 13th. Truist Securities increased their price target on UnitedHealth Group from $480.00 to $500.00 and gave the stock a “buy” rating in a research report on Friday, July 16th. Finally, Credit Suisse Group increased their price target on UnitedHealth Group from $430.00 to $462.00 and gave the stock an “outperform” rating in a research report on Friday, July 16th. Three analysts have rated the stock with a hold rating, twenty have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $447.79.

UnitedHealth Group Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Read More: What is a good dividend yield?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.